Form D · Biotechnology

Galaxy Diagnostics, Inc.

Durham, NC · CIK 0001462444

Offering snapshot reported Jun 3, 2026 · SEC filing

Reported sold
$3.02M
Offering amount: $5.7M
Investors reported
45
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 1, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2026Initial$3,019,645No comparison45SEC filing
Apr 22, 2025Initial$4,141,184No comparison55SEC filing
Jul 31, 2024Amendment$2,026,000$1,201,000vs Jul 10, 202427SEC filing
Jul 10, 2024Initial$825,000No comparison13SEC filing
Aug 15, 2014Initial$550,814No comparison7SEC filing
May 12, 2009Initial$40,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-586034

Source: Form D, filed Jun 3, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicole Bell Director, Executive
Edward Breitschwerdt Director
B. Jefferson Clark Director, Executive
Amanda Elam Director
Christopher Kelly Director, Executive
Joel Kimbrough Director
Ricardo Maggi Director
Richard West Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6 Davis Drive Suite 832
Durham, NC, 27713